1. Home
  2. FTK vs IMTX Comparison

FTK vs IMTX Comparison

Compare FTK & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flotek Industries Inc.

FTK

Flotek Industries Inc.

N/A

Current Price

$24.57

Market Cap

937.2M

Sector

Industrials

ML Signal

N/A

Logo Immatics N.V.

IMTX

Immatics N.V.

N/A

Current Price

$6.32

Market Cap

992.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FTK
IMTX
Founded
1985
N/A
Country
United States
Germany
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
937.2M
992.8M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
FTK
IMTX
Price
$24.57
$6.32
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
9
Target Price
★ $39.42
$15.97
AVG Volume (30 Days)
270.8K
★ 1.0M
Earning Date
11-03-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 147.06
N/A
EPS
★ 0.72
N/A
Revenue
★ $136,092,000.00
N/A
Revenue This Year
$62.65
N/A
Revenue Next Year
$11.85
$14.22
P/E Ratio
$34.50
★ N/A
Revenue Growth
★ 214.53
N/A
52 Week Low
$13.19
$6.06
52 Week High
$39.67
$12.41

Technical Indicators

Market Signals
Indicator
FTK
IMTX
Relative Strength Index (RSI) 46.82 36.00
Support Level $21.45 N/A
Resistance Level $25.39 $7.95
Average True Range (ATR) 1.89 0.47
MACD 0.12 -0.01
Stochastic Oscillator 35.44 19.81

Price Performance

Historical Comparison
FTK
IMTX

About FTK Flotek Industries Inc.

Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.

About IMTX Immatics N.V.

Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Share on Social Networks: